About Y-mAbs Therapeutics
Y-mAbs is a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer.
- Employees
- 125
- Headquarters
- New York
Leadership
The top of Y-mAbs Therapeutics's org chart, with how many people report into each leader.
Thomas Gad
Chairman & CEO
55 reports
Joris Wilms
SVP & COO
23 reports
Sue Smith
SVP, CCO
20 reports
Peter Pfreundschuh
Chief Financial Officer
4 reports
Sune Nyland
VP, General Counsel
1 report
Norman LaFrance
Chief Development Officer, Y-mAbs Therapeutics, Inc
Nancy Momcilovic
Executive Administrator
Doug Gentilcore
Senior Vice President, Head of Danyleza Business Unit
Board
Johan Wedell-Wedellsborg
Majority shareholder / Boardmember
Ashutosh Tyagi
Director
James I. Healy
Director
David N. Gill
Board member; chairman of audit committee
Laura J. Hamill
Director
Gérard Ber
Director
Jobs at Y-mAbs Therapeutics
No open positions right now. Explore more companies on TheJobsMap.